Intramammary lymph nodes: Patterns of discovery and clinical significance

Sandeep S. Vijan, Steven Hamilton, Beiyun Chen, Carol Reynolds, Judy C Boughey, Amy C Degnim

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: We sought to determine how often axillary node metastases were present in patients with intramammary lymph node (IMLN) metastasis and if the method of IMLN discovery impacts likelihood of axillary node metastasis. Methods: A retrospective review of our breast cancer database was conducted to identify patients in whom an IMLN was found. IMLNs were classified into 2 groups: those found "preoperatively" (evident on mammography, ultrasonography, magnetic resonance imaging or lymphogram), and those found "incidentally" (found by the surgeon intraoperatively or on pathologic review). Patterns of discovery and their correlation with axillary disease were evaluated using Fisher's exact test. Results: Between March 1994 and October 2007, IMLNs were identified in 93 breast specimens. Twenty-three IMLNs were found preoperatively, while 70 were identified incidentally. Thirty-two patients (34%) harbored cancer in IMLNs with additional axillary node involvement present in 22 (69%). Metastasis was more frequent in the IMLNs detected by imaging (10/23, 43%) than in IMLNs detected incidentally (22/70, 31%, P = NS). Patients with positive IMLNs were more likely to have axillary disease than patients with negative IMLNs (69% versus 18%, P < .0001). Conclusion: The majority of identified IMLNs are histologically negative. If breast cancer is identified in an IMLN, additional axillary lymph node disease is common, regardless of the method of detection of the IMLN.

Original languageEnglish (US)
Pages (from-to)495-499
Number of pages5
JournalSurgery
Volume145
Issue number5
DOIs
StatePublished - May 2009

Fingerprint

Lymph Nodes
Neoplasm Metastasis
Breast Neoplasms
Mammography
Ultrasonography
Breast
Magnetic Resonance Imaging
Databases
Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Intramammary lymph nodes : Patterns of discovery and clinical significance. / Vijan, Sandeep S.; Hamilton, Steven; Chen, Beiyun; Reynolds, Carol; Boughey, Judy C; Degnim, Amy C.

In: Surgery, Vol. 145, No. 5, 05.2009, p. 495-499.

Research output: Contribution to journalArticle

Vijan, Sandeep S. ; Hamilton, Steven ; Chen, Beiyun ; Reynolds, Carol ; Boughey, Judy C ; Degnim, Amy C. / Intramammary lymph nodes : Patterns of discovery and clinical significance. In: Surgery. 2009 ; Vol. 145, No. 5. pp. 495-499.
@article{c06e2b50c5d6434097dbc9688b5aac9b,
title = "Intramammary lymph nodes: Patterns of discovery and clinical significance",
abstract = "Background: We sought to determine how often axillary node metastases were present in patients with intramammary lymph node (IMLN) metastasis and if the method of IMLN discovery impacts likelihood of axillary node metastasis. Methods: A retrospective review of our breast cancer database was conducted to identify patients in whom an IMLN was found. IMLNs were classified into 2 groups: those found {"}preoperatively{"} (evident on mammography, ultrasonography, magnetic resonance imaging or lymphogram), and those found {"}incidentally{"} (found by the surgeon intraoperatively or on pathologic review). Patterns of discovery and their correlation with axillary disease were evaluated using Fisher's exact test. Results: Between March 1994 and October 2007, IMLNs were identified in 93 breast specimens. Twenty-three IMLNs were found preoperatively, while 70 were identified incidentally. Thirty-two patients (34{\%}) harbored cancer in IMLNs with additional axillary node involvement present in 22 (69{\%}). Metastasis was more frequent in the IMLNs detected by imaging (10/23, 43{\%}) than in IMLNs detected incidentally (22/70, 31{\%}, P = NS). Patients with positive IMLNs were more likely to have axillary disease than patients with negative IMLNs (69{\%} versus 18{\%}, P < .0001). Conclusion: The majority of identified IMLNs are histologically negative. If breast cancer is identified in an IMLN, additional axillary lymph node disease is common, regardless of the method of detection of the IMLN.",
author = "Vijan, {Sandeep S.} and Steven Hamilton and Beiyun Chen and Carol Reynolds and Boughey, {Judy C} and Degnim, {Amy C}",
year = "2009",
month = "5",
doi = "10.1016/j.surg.2009.01.015",
language = "English (US)",
volume = "145",
pages = "495--499",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Intramammary lymph nodes

T2 - Patterns of discovery and clinical significance

AU - Vijan, Sandeep S.

AU - Hamilton, Steven

AU - Chen, Beiyun

AU - Reynolds, Carol

AU - Boughey, Judy C

AU - Degnim, Amy C

PY - 2009/5

Y1 - 2009/5

N2 - Background: We sought to determine how often axillary node metastases were present in patients with intramammary lymph node (IMLN) metastasis and if the method of IMLN discovery impacts likelihood of axillary node metastasis. Methods: A retrospective review of our breast cancer database was conducted to identify patients in whom an IMLN was found. IMLNs were classified into 2 groups: those found "preoperatively" (evident on mammography, ultrasonography, magnetic resonance imaging or lymphogram), and those found "incidentally" (found by the surgeon intraoperatively or on pathologic review). Patterns of discovery and their correlation with axillary disease were evaluated using Fisher's exact test. Results: Between March 1994 and October 2007, IMLNs were identified in 93 breast specimens. Twenty-three IMLNs were found preoperatively, while 70 were identified incidentally. Thirty-two patients (34%) harbored cancer in IMLNs with additional axillary node involvement present in 22 (69%). Metastasis was more frequent in the IMLNs detected by imaging (10/23, 43%) than in IMLNs detected incidentally (22/70, 31%, P = NS). Patients with positive IMLNs were more likely to have axillary disease than patients with negative IMLNs (69% versus 18%, P < .0001). Conclusion: The majority of identified IMLNs are histologically negative. If breast cancer is identified in an IMLN, additional axillary lymph node disease is common, regardless of the method of detection of the IMLN.

AB - Background: We sought to determine how often axillary node metastases were present in patients with intramammary lymph node (IMLN) metastasis and if the method of IMLN discovery impacts likelihood of axillary node metastasis. Methods: A retrospective review of our breast cancer database was conducted to identify patients in whom an IMLN was found. IMLNs were classified into 2 groups: those found "preoperatively" (evident on mammography, ultrasonography, magnetic resonance imaging or lymphogram), and those found "incidentally" (found by the surgeon intraoperatively or on pathologic review). Patterns of discovery and their correlation with axillary disease were evaluated using Fisher's exact test. Results: Between March 1994 and October 2007, IMLNs were identified in 93 breast specimens. Twenty-three IMLNs were found preoperatively, while 70 were identified incidentally. Thirty-two patients (34%) harbored cancer in IMLNs with additional axillary node involvement present in 22 (69%). Metastasis was more frequent in the IMLNs detected by imaging (10/23, 43%) than in IMLNs detected incidentally (22/70, 31%, P = NS). Patients with positive IMLNs were more likely to have axillary disease than patients with negative IMLNs (69% versus 18%, P < .0001). Conclusion: The majority of identified IMLNs are histologically negative. If breast cancer is identified in an IMLN, additional axillary lymph node disease is common, regardless of the method of detection of the IMLN.

UR - http://www.scopus.com/inward/record.url?scp=64449087615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64449087615&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2009.01.015

DO - 10.1016/j.surg.2009.01.015

M3 - Article

C2 - 19375607

AN - SCOPUS:64449087615

VL - 145

SP - 495

EP - 499

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 5

ER -